Terms: = Leukemia AND JAK3, L-JAK, 3718, ENSG00000105639, P52333, JAKL, JAK-3, LJAK, JAK3_HUMAN
219 results:
1. Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
[TBL] [Abstract] [Full Text] [Related]
2. Synthesis, kinase inhibition and anti-leukemic activities of diversely substituted indolopyrazolocarbazoles.
Frazier T; Pereira E; Aesoy R; Nauton L; Giraud F; Herfindal L; Anizon F; Moreau P
Eur J Med Chem; 2024 Apr; 269():116352. PubMed ID: 38537512
[TBL] [Abstract] [Full Text] [Related]
3. Janus Kinase 3 (jak3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency.
Liongue C; Ratnayake T; Basheer F; Ward AC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474223
[TBL] [Abstract] [Full Text] [Related]
4. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
[TBL] [Abstract] [Full Text] [Related]
5. N-Acetylcysteine Alters Disease Progression and Increases Janus Kinase Mutation Frequency in a Mouse Model of Precursor B-Cell Acute Lymphoblastic leukemia.
Sams MP; Iansavitchous J; Astridge M; Rysan H; Xu LS; Rodrigues de Oliveira B; DeKoter RP
J Pharmacol Exp Ther; 2024 Mar; 389(1):40-50. PubMed ID: 38336380
[TBL] [Abstract] [Full Text] [Related]
6. Folate-Appended Hydroxypropyl-β-Cyclodextrin Induces Autophagic Cell Death in Acute Myeloid leukemia Cells.
Kubota Y; Hoshiko T; Higashi T; Motoyama K; Okada S; Kimura S
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069042
[TBL] [Abstract] [Full Text] [Related]
7. The jak3
Lahera A; Vela-Martín L; Fernández-Navarro P; Llamas P; López-Lorenzo JL; Cornago J; Santos J; Fernández-Piqueras J; Villa-Morales M
Mol Carcinog; 2024 Jan; 63(1):5-10. PubMed ID: 37712558
[TBL] [Abstract] [Full Text] [Related]
8. Partial response to venetoclax and ruxolitinib combination in a case of refractory T-prolymphocytic leukemia.
Brothers J; Castillo DR; Jeon WJ; Joung B; Linhares Y
Hematology; 2023 Dec; 28(1):2237342. PubMed ID: 37485976
[No Abstract] [Full Text] [Related]
9. Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic leukemia.
Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
[TBL] [Abstract] [Full Text] [Related]
10. [Genomics of next generation sequencing in pediatric B-acute lymphoblastic leukemia and its impact on minimal residual disease].
Gao YY; Jia YJ; Qi BQ; Zhang XY; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Wang SC; Zhang RR; Liu TF; Song Z; Zhu XF; Chen XJ
Zhonghua Er Ke Za Zhi; 2023 Jun; 61(6):527-532. PubMed ID: 37312464
[No Abstract] [Full Text] [Related]
11. MiR-708 regulates the biological behavior of childhood leukemia cells by binding to the 3'utr end of the target gene and reducing the level of the target gene.
Li Y; Zhang Y; Guan L
Cell Mol Biol (Noisy-le-grand); 2023 Feb; 69(2):157-161. PubMed ID: 37224029
[TBL] [Abstract] [Full Text] [Related]
12. JAK1 Pseudokinase V666G Mutant Dominantly Impairs jak3 Phosphorylation and IL-2 Signaling.
Grant AH; Rodriguez AC; Rodriguez Moncivais OJ; Sun S; Li L; Mohl JE; Leung MY; Kirken RA; Rodriguez G
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047778
[TBL] [Abstract] [Full Text] [Related]
13. T-Cell Prolymphocytic leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
Hu Z; Medeiros LJ; Xu M; Yuan J; Peker D; Shao L; Tang Z; Mai B; Thakral B; Rios A; Hu S; Wang W
Am J Clin Pathol; 2023 Apr; 159(4):325-336. PubMed ID: 36883805
[TBL] [Abstract] [Full Text] [Related]
14. 2-Aminopyrimidine derivatives as selective dual inhibitors of JAK2 and FLT3 for the treatment of acute myeloid leukemia.
Xu S; Zhu Y; Meng J; Li C; Zhu Z; Wang C; Gu YC; Han L; Wen J; Tong M; Shi X; Hou Y; Liu Y; Zhao Y
Bioorg Chem; 2023 May; 134():106442. PubMed ID: 36878064
[TBL] [Abstract] [Full Text] [Related]
15. Zebrafish Model of Severe Combined Immunodeficiency (SCID) Due to jak3 Mutation.
Basheer F; Lee E; Liongue C; Ward AC
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291730
[TBL] [Abstract] [Full Text] [Related]
16. JAK: Not Just Another Kinase.
Agashe RP; Lippman SM; Kurzrock R
Mol Cancer Ther; 2022 Dec; 21(12):1757-1764. PubMed ID: 36252553
[TBL] [Abstract] [Full Text] [Related]
17. IL-7: Comprehensive review.
Winer H; Rodrigues GOL; Hixon JA; Aiello FB; Hsu TC; Wachter BT; Li W; Durum SK
Cytokine; 2022 Dec; 160():156049. PubMed ID: 36201890
[TBL] [Abstract] [Full Text] [Related]
18. TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.
Zhang H; Zhan Q; Wang X; Gao F; Yu J; Wang J; Fu W; Wang P; Wei X; Zhang L
Ann Hematol; 2022 Dec; 101(12):2583-2600. PubMed ID: 36181538
[TBL] [Abstract] [Full Text] [Related]
19. The mRNA Expression of
Lak ER; Tamaddon G; Ramzi M; Ranjbaran R; Abedi E; Sharifzadeh S
Cardiovasc Hematol Agents Med Chem; 2023; 21(1):67-76. PubMed ID: 35993473
[TBL] [Abstract] [Full Text] [Related]
20. Transformation from polycythemia vera to acute promyelocytic leukemia: Case report and literature review.
Li WW; Sui XF; Fan S; Xu H; Wang CL; Wang FY; Mo XD
Medicine (Baltimore); 2022 Aug; 101(32):e30064. PubMed ID: 35960050
[TBL] [Abstract] [Full Text] [Related]
[Next]
